FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for omeprazole submitted by Sandoz Inc under ANDA075757 (generic omeprazole).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease

Drugs mentioned

• Omeprazole (Omeprazole)

Snippet

SUPPL AP for OMEPRAZOLE (OMEPRAZOLE)